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Abstract: Thiosemicarbazones and their metal derivatives have long been screened as antitumor 
agents and their interactions with DNA have been analyzed. Here, we describe the synthesis and 
characterization of compounds containing [CuL]+ entities (HL = pyridine-2-carbaldehyde 
thiosemicarbazone) and adenine, cytosine or 9-methylguanine, and some of their corresponding 
nucleotides. For the first time, crystal structures of adenine- and 9-methylguanine-containing 
thiosemicarbazone complexes are reported. To our knowledge, the first research on the affinity 
thiosemicarbazone-RNA is also provided here. Experimental and computational studies have shown 
that [CuL(OH2)]
+ entities at low concentration intercalate into dsRNA poly(rA)•poly(rU) through 
strong hydrogen bonds, involving uracil residues and π–π stacking interactions. In fact, noncovalent 
interactions are present both in the solid state and in solution. This behaviour diverges from that 
observed with DNA duplexes and creates an optimistic outlook in achieving selective binding to RNA 
and its possible medical applications.  
Introduction 
Ever since the middle of the last century, Brockman et al.1 began observing anticarcinogenic evidence 
in the pyridine-2-carbaldehyde thiosemicarbazone molecule (HL, see Scheme 1 with the atom labels 
used in this work, R1 = R2 = R3 = H), the biological properties of thiosemicarbazones have attracted 
growing attention.2,3 In particular, those related to their use as antitumour agents have led to clinical 
trials on HL analogues such as 5-hydroxypyridine-2-carbaldehyde thiosemicarbazone (R1 = OH, R2 = 
R3 = H)
4 and 3-aminopyridine-2-carbaldehyde thiosemicarbazone (R1 = R3 = H, R2 = NH2, Triapine
®), 
the latter reaching the Phase II stage.5 Promising preliminary cytotoxic effects against tumour cells 
have also been detected with metal complexes derived from HL,6 those with Cu(II) being especially 
remarkable;7 actually, the thiosemicarbazone-copper interplay in cells seems to be key to the biological 
activity of these substances.8  In particular, Cu(II) ion has aroused special interest due to its rich 
spectroscopic and magnetic properties that often change in the course of enzyme catalysis.9 To explain 
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these interesting features, biochemical studies have revealed that ribonucleotide reductases are usual 
targets for thiosemicarbazones10 and, though less studied, other enzymes are also affected.11 However, 
thiosemicarbazones can also interact with nucleotide sequences by either intercalation12 or external 
binding13 and, depending on the ligand shape and structure, these compounds can interact with specific 
polynucleotide sequences. 14  The reaction of DNA with thiosemicarbazonecopper(II) complexes 
containing heterocyclic ancillary ligands has also been studied. Mechanistic investigations point to 
either minor or major groove binding, depending on the complex structure.13,15,16 Unfortunately, the 
lack of crystallographic support confers uncertainty to the structural features of the interaction. 
Previous studies in aqueous solution with [CuL]+ and [CuL´]+ entities (HL´ = pyridine-2-carbaldehyde 
N4-methylthiosemicarbazone, R1 = R2 = H, R3 = CH3, see Scheme 1) reveal binding interaction with 
adenine (Hade), cytosine (Hcyt), guanine (Hgua) and their corresponding nucleoside monophosphates, 
but not with thymine and thymidine-5’-monophosphate. The most probable linkage proceeds through 
the nucleobase N sites instead of the phosphate groups, as inferred from the crystal structure of the 
[CuL(Hcyt)](ClO4) derivative.
17 The interaction of these thiosemicarbazonatocopper(II) species with 
[poly(dA–dT)]2, [poly(dG–dC)]2 and ctDNA has also been evaluated, concluding that they undergo 
groove binding with the  DNA A−T tract.18 
 
Scheme 1 Atom labels for the thiosemicarbazone ligands. 
RNA is involved in a variety of processes in the regulation of the gene expression and can adopt a 
number of structures and conformations. This polymer displays several cellular functions and provides 
specific binding sites for small molecules.19 These conformations offer attractive potential targets for 
drugs able to bind specifically to such structures, thus enabling the inhibition of the viral 
transcription.20 
The molecular requirements for recognition of the duplex RNA have not yet been established. The 
binding to DNA by organic cation drugs such as Hoechst 33258, berenil or DAPI, exhibit high affinity 
with the minor groove of A−T tract DNA and intercalate into the RNA duplex. Therefore, the 
interaction with such molecules creates an optimistic outlook in achieving selective binding of RNA 
duplex over DNA duplex by tweaking the molecular structure.21 This binding event requires local 
opening of the RNA double helix, so the recognition may lie within duplex areas adjacent to bulges or 
loops, where such opening is available for threading. As we shall see below, a similar behaviour 
occurs with [CuL]+. To our knowledge, this is the first study on the recognition of duplex RNA by 
tiosemicarbazones.  
To get some insight into the possible binding of thiosemicarbazonatocopper(II) species to DNA, RNA 
and⁄or free nucleotide-contained fragments, we present here the crystal structures of compounds in 
which [CuL]+ entities are linked to Hade, 9-methylguanine (9-Mgua) and Hcyt. Rational synthetic 
Page 2 of 27Dalton Transactions
D
al
to
n
Tr
an
sa
ct
io
ns
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
26
 O
ct
ob
er
 2
01
6.
 D
ow
nl
oa
de
d 
by
 U
ni
ve
rs
id
ad
 d
e B
ur
go
s o
n 
27
/1
0/
20
16
 0
9:
07
:2
4.
 
View Article Online
DOI: 10.1039/C6DT02907H
procedures to get them and some related nucleotides are also discussed (see Scheme 2). Moreover, the 
interactions of [CuL]+ with 9-Mgua, uracil and poly(rA)poly(rU) are studied and the biological 
relevance of the achieved results is evaluated as well. To date, only one work describing crystal 
studies on the interaction between thiosemicarbazones and nucleobases has been published.17 Other 
previous studies have incorporated thiosemicarbazone moieties inside the nucleobase, generating 5-
formyluracil thiosemicarbazone ligands.15, 22  Structural comparison with related Cu(II)-nucleobase 
systems is discussed to explore the involvement of the noncovalent interactions in the affinity of metal 
complexes with DNA and RNA.  
 
 
Scheme 2. Summary of the synthesised compounds. 
Results and Discussion 
Synthesis. Several experiments carried out on the ade−⁄Hade system using water as the only solvent 
yielded compound 1 even at pH 2.0, which confirms the stability of the deprotonated ade− species in 
the [{CuL}{CuL(OH2)}(ade)]
+ cation within the pH 2−7 range. Compounds containing both the 
neutral (Hade) and deprotonated (ade−) ligands as 2, were isolated as solids with different water 
content through water/methanol mixtures. 
Lack of positive results for the attempts with uracil, thymine and their corresponding nucleotides 
could be related to the need for sufficient basic aqueous media to ensure deprotonation and further 
coordination of the nucleobase. In the same way, the low solubility of Hgua in water at physiological 
pH could prevent from precipitation and isolation of stable ternary complexes. Therefore, we tried to 
deprotonate the Hgua at pH > 9.0 but, under such reaction conditions, [CuL]+ entities underwent 
desulfurization that led to formation of [CuL(LCN)] 23  [HLCN = pyridine-2-
ylmethylene(hydrazinecarbonitrile)] or [CuLCl]2[Cu(pic)2]
 24 (Hpic = picolinic acid). In fact, partial 
transformation of [CuL]+ entities into nitrile derivatives in aqueous solutions can be observed even at 
physiological pH 7.4.23,24 The conversion in aqueous basic media of sulfur thioamide into sulfate for 
HL/HL’-Cu(II) species has also been reported.25 The observed higher solubility in water prompted us 
to use 9-Mgua instead of Hgua, and then we obtained compound 3.  
Several trials to attain diverse nucleotide-containing compounds yielded powdered samples for 
adenosine-5´-monophosphate (H2AMP) and adenosine-5´-triphosphate (H4ATP) with large amounts of 
water, as described below. Attempts using sodium guanosine-5´-monophosphate (Na2GMP) were 
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unsuccessful, whereas solids isolated from cytidine-5´-monophosphate (H2CMP) point to formulae 
(CuL)2(HCMP)(ClO4)(H2O) and (CuL´)2(HCMP)(ClO4)(H2O)4, but absence of impurities could not be 
guaranteed (see Supporting Information). All the efforts for crystallizing the nucleotide derivatives 
were futile. Thermal decomposition of the nucleobase-containing compounds at 700 ºC yielded CuO 
(JCPDS No. 72-0629 and 74-1021),26 while the solid residues in the nucleotide derivatives were a 
mixture of CuO and some peaks assigned to Cu3(PO4)2 (JCPDS No. 80-0991), except for the ATP-
containing 12 compound, which only showed X-ray peaks of Cu2(P2O7) (JCPDS No. 21-0299, see 
Figs. S12, S13 and description in Supporting Information). 
 
Crystal structures.  Figures 1- 4 depict the drawings with main motifs in the crystal structures of 
[{CuL}{CuL(OH2)}(ade)](ClO4) 1, [(CuL)2(Hade)][{CuL}{CuL(OClO3)}(ade)](ClO4)2·2H2O 2, 
[{CuL(9-Mgua)}2(OH2)](ClO4)2 3 and [CuL(Hcyt)](ClO4)·2H2O 4. Detailed description of the crystal 
features is given in Supporting Information. All these compounds incorporate anionic tridentate 
thiosemicarbazones linked to the Cu(II) ions through the Npyridine, Nazomethine and Sthioamide donor atoms, 
in good agreement with the structural parameters previously reported to distinguish the anion versus 
neutral forms of the ligand in thiosemicarbazonecopper(II) complexes (see Table S2, Supporting 
Information).27  
 
Fig. 1. Crystal structure of the [{CuL}{(CuL)(OH2)}(ade)]
+ entity in 1. Thermal ellipsoids are drawn at 30% 
probability level. 
 
Briefly, 1 and 2 contain dinuclear entities (Figs. 1 and 2, Table S3), where one adenine (µ-κN3: κN9) 
ligand, neutral or deprotonated after removal of the N7-linked hydrogen atom, acts as a bridge 
between the Cu(II) ions, retaining the coordinative character usually shown by this nucleobase in non-
thiosemicarbazone systems, i.e. on paddle wheel adenine complexes.28  Another common topic in 
these compounds is the bridging role of the thioamide sulfur atom, clearer for 2 with Cu–S’ distances 
in the 2.80–2.90 Å range, while the length for 1 is 3.094(3) Å, regarded as borderline of a real bond 
despite the place of S12 atom and the Jahn-Teller effect on the Cu(II) ion support the 
pseudocoordination. Distorted square-planar, elongated octahedral and square-pyramidal29 topologies 
around the metal centres are found in these compounds.  
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 Fig. 2. Crystal structure of the [(CuL)2(Hade)]
2+ (a) and [{CuL}{CuL(OClO3)}{ade}] (b) entities in 2. Thermal 
ellipsoids are drawn at the 20% probability level. 
 
3 is made of dinuclear units where square pyramidal Cu(II) ions present in [CuL(9-Mgua)]+ fragments 
are linked by the oxygen atom of a bridging water molecule (Fig. 3, Table S4).  
 
Fig. 3. Crystal structure of [{CuL(9-Mgua)}2(OH2)]
2+ entities (a) and the labelling of its asymmetric unit (b) in 
3. Thermal ellipsoids are drawn at the 50% probability level.  
 
(a) 
(b) 
(b) 
(a)  
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Complex 4 is built up by [CuL(Hcyt)]+ monomer units (Fig. 4, Table S4) containing Cu(II) ions with 
distorted square–planar topology. Notwithstanding, the intramolecular Cu···O12 distance, 2.754(6) Å, 
could be interpreted as a (4+1) pseudocoordination and falls inside the 2.55–2.88 Å range reported in 
the literature for the cytosine Cu–O bonds.30,31 The weakness of such a linkage is suggested by the 
value of the C12–O12 bond length, 1.246(9) Å, which does not significantly differ from 1.237(2) Å in 
the free Hcyt. 32  The molecular structure of 4 is quite similar to the analogous dehydrated 
[CuL(Hcyt)](ClO4) (5) compound.
17 A common feature is the formation of π–π stacked dimeric 
aggregates, which are also stabilized through intra-dimer (N14–H14···N3) hydrogen bonds. However, 
the entry of water molecules, mainly placed around the cytosine rings (up to seven water molecules 
closer than 4 Å from cytosine ring), induces differences in the lattice (see Fig. S1).  
 
Fig. 4. Crystal structure of [CuL(Hcyt)]+ entities in 4. Thermal ellipsoids are drawn at the 50% probability level. 
 
A plethora of noncovalent interactions are responsible for the stabilization of the structures described 
here, such as π–π stacking, anion–π or hydrogen bonds (see text, Figs. S2–S4 and Tables S5–S7 in 
Supporting Information). Taking into account the different planar moieties, three possible types of π–π 
stacking could be considered, namely thiosemicarbazone···thiosemicarbazone, 
nucleobase···nucleobase and thiosemicarbazone···nucleobase, (Scheme 3a to 3c). In our case, 
although the most prominent π–π stacking interactions are those involving thiosemicarbazones for all 
of the studied structures (Scheme 3a), thiosemicarbazone···nucleobase interactions (compound 2) and 
nucleobase···nucleobase (compounds 3 and 4) are also observed (see Table S9). On the other side, 
hydrogen bonds are set up between thiosemicarbazones and nucleobase N atoms. 
 
Spectroscopic and magnetic characterization. The usual IR bands for the pyridine-2-carbaldehyde 
thiosemicarbazonatocopper(II) entities,33 together with those of the corresponding nucleobases and that 
attributed to perchlorate, nitrate and phosphate groups are observed (see Experimental Section, 
description in Supporting Information and Figs. S5–S10). Distortion in the perchlorate ions becomes 
υ1 and υ2 into IR active modes, similar to those described for a cytosinecopper(II) derivative
31 
containing free perchlorate anions involved in strong hydrogen bonds. The very strong band at 1632 
cm–1 for 4 can be assigned to the ν(CO) upon (C=O···Cu) coordination17 and shifts to higher energy 
(1664 cm–1) in free Hcyt, which supports the pseudocoordination between the Cu(II) ion and the 
oxygen carbonyl atoms.34 However, the band associated to ν(CO) in 3 appears at 1683 cm–1, without 
variation respect to the free 9-Mgua. The EPR signals and average g values are similar to those 
reported in the Literature for other nucleobase- and nucleotidecopper(II) derivatives (Fig. S11 and 
Experimental Section).35 A more detailed discussion is given in Supporting Information.  
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 Scheme 3. Drawing of the π–π stacking (dotted lines) between thiosemicarbazonecopper(II) entities (green) (a), 
biomolecules aromatic rings (orange) (b) and between thiosemicarbazones and biomolecules (c). Proposed 
interaction mechanism between RNA and [CuL(OH2)]
+, at low (d) and high (e) concentration of [CuL(OH2)]
+. 
Red, orange and green blocks stand for uracil, Hade and [CuL(OH2)]
+, respectively, dotted lines stand for π–π 
stacking and dashed lines for H-bonding. 
 
The thermal evolution of χm and χmT for 1 (Fig. 5) is characteristic of antiferromagnetic behaviour, but 
all our attempts to fit it to analytical expressions for dinuclear or 1D Cu(II) systems were unsuccessful. 
The presence of interdinuclear interactions in compound 1 cannot be discarded. In this regard, we tried 
to evaluate the influence of intermolecular interactions by measuring the magnetic susceptibility of the 
monomer compound 5 (Fig. 6). The curve also denotes the presence of antiferromagnetic interactions 
and was fitted by Bleaney–Bowers equation 36  for dinuclear Cu(II) compounds derived from 
Heisenberg isotropic spin Hamiltonian H = –2JS1S2. The best least-square fitting is reached for J/K = –
2.3 K and g = 2.109, which is very similar to that measured by EPR, g = 2.085. 
 
Fig. 5. Graphics of χm (◊◊◊), and χmT  () versus T for 1.  
 
To explain the weak antiferromagnetic behaviour detected in 5, two possible exchange pathways 
through noncovalent contacts can be proposed. On one hand, the already described π–π stacking, that 
involves chelating rings of different [CuL(Hcyt)]+ entities with centroid···centroid distances in the 
3.25–3.73 Å range but, even clearer, a separation between the copper and N3 nitrogen atom from a 
neighbour monomer of only 2.92 Å. Magnetic propagation through π–π stacking has been described 
for other Cu(II)-containing monomers37 and dimers.38 Other possible pathway for exchange coupling 
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would be the hydrogen bonding that relates the closest Cu1A and Cu1B centres in 5. The presence of 
even relatively intense magnetic coupling in hydrogen bonded Cu(II)-monomeric compounds has been 
discussed both in experimental39 and theoretical studies.40 Taking into account the presence of weak 
antiferromagnetic coupling in 5 despite the very short Cu···Cu distance in its structure, we suggest that 
the magnetic interactions in 1, clearly stronger than those in 5, are mainly intradinuclear in nature.  
 
 
Fig. 6. χm (◊◊◊) and χmT  () versus T plots for 5. The corresponding fittings are represented by continuous 
lines.  
 
Interaction of [CuL]+ with RNA in aqueous solution.  
In an earlier contribution,17 we showed that [CuL]+ interacts in aqueous solution with the nucleobases 
Hade, Hgua and Hcyt and their corresponding nucleotides dAMP, dGMP and dCMP, the affinity with 
the nucleobases being greater. For thymine and dTMP no interaction was observed. The equilibrium 
constant showed that methylation of the N9 guanine site considerably reduces the affinity with [CuL]+. 
Thus, the apparent binding constant, Kapp = 6.3×10
4 M−1 for the CuL(9-Mgua) complex is two orders 
less than that measured for the CuL(gua) complex, Kapp = 5.4×10
6 M−1. This result indicates that 
[CuL]+ in solution mainly interacts with the N9 guanine site, but other types of interaction are also 
feasible.  
The interaction of [CuL]+ with [poly(dA–dT)]2, [poly(dG–dC)]2, and ctDNA has been probed in 
aqueous solution at pH 6.0, I = 0.1 M, and T = 25 ºC, revealing that this metal complex acts as a 
groove binder with [poly(dA–dT)]2 whereas it acts as a weak external binder with [poly(dG–dC)]2 and 
ctDNA. By contrast, the [CuL]+ binding to RNA still remains unexplored. In this section, we show 
that stacking interactions of the thiosemicarbazone···nucleobase and thiosemicarbazone··· 
thiosemicarbazone types are present also in solution in near physiological conditions. Moreover, 
hydrogen bond and electrostatic interactions also govern the formation of [CuL]+ /RNA complex. 
To gain some more insights into the possible interaction of the thiosemicarbazonecopper(II) dye with 
RNA, it is important to learn the binding ability of [CuL]+ towards uracil. Uracil bears close similarity 
with thymine and in neither case coordination to [CuL]+ has been observed. However, H bond between 
the H2O ligands linked to [CuL]
+ and the oxygen of uracil in A−U base pairs is possible, as shown 
below.  
The binding of [CuL]+ to the synthetic RNA double helix, poly(rA)poly(rU) can be represented in 
terms of Eq. (1),  
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P + D   PD
K
 (1) 
where P and D stand for the poly(rA)poly(rU) free binding sites and [CuL]+, respectively, and PD 
stands for [CuL]+/ poly(rA)poly(rU) complex, CD and CP being the analytical P and D concentrations, 
respectively.  
The thermal stability of the poly(rA)poly(rU) double helix was studied by DSC in the absence and in 
the presence of different amounts of [CuL]+. The melting temperature increased (∆Tm = 28ºC) tending 
to a plateau at CD/CP = 0.1 ( Fig. 7a), indicating that poly(rA)poly(rU) becomes strongly stabilized 
for very low [CuL]+ concentration; the pronounced increase in Tm can be consistent with an 
intercalated complex formed by one [CuL]+ entity every ten RNA base-pairs, that is, n´= 10. By 
contrast, for the [CuL]+/[poly(dA–dT)]2 system, it turned out ∆Tm = 0.6ºC in the same concentration 
range;17 thus, thermal stabilization of DNA by [CuL]+ is less than for RNA, evincing the possibility of 
molecular recognition of duplex RNA over duplex DNA. As computational calculations will 
demonstrate (see below), intercalation and hydrogen bonds yield an interstrand-intercalated [CuL]+ 
/RNA complex that can explain the strong stabilization of the RNA double helix by [CuL]+ .  
  
Fig. 7. a) DSC Melting temperature, Tm, versus CD/CP ratio. CP = 0.5 mM; b) Variation of contour length with 
CD/CP ratio for the [CuL]
+/poly(rA)•poly(rU) system. CP = 0.2 mM.  I = 2.5 mM, pH = 6.0 and T = 25 ºC. 
 
The DSC results are supported by viscosity measurements. The viscosity ratio η/η0, where η0 is the 
viscosity of the polymer alone and η is the viscosity of the dye/polynucleotide system, is related to the 
polynucleotide elongation by L/L0 = (η/η0)
1/3,41 where L is the contour length of the dye/polynucleotide 
system and L0 is that of the free polynucleotide. L/L0 was plotted as a function of the CD/CP ratio. The 
evolution of the RNA contour length with the increase in relative viscosity (Fig. 7b), confirms the 
formation of an intercalated complex at low [CuL]+ /RNA ratio, CD/CP ∼ 0.1. By contrast, the 
diminution of viscosity for CD/CP > 0.1 indicates that a new complex is forming upon increase of the 
[CuL]+ concentration. Figure S14 compares the viscosity data here described with those relative to 
different [CuL]+ /DNA systems.18 Unlike RNA, with DNA the L/L0 ratio remained constant, indicating 
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that the type of binding strongly depends on the type of polynucleotide, RNA or DNA. The results 
attained with RNA for low CD/CP are consistent with intercalation up to CD/CP = 0.1, and with external 
or groove binding with DNA throughout the overall concentration range. Computational calculations 
bear out these conclusions and explain the main features of the intercalated [CuL]+/ RNA complex. 
The mode of interaction of [CuL]+ with poly(rA)poly(rU) for the intercalative behaviour was 
optimized with two poly(rA)poly(rU) base-pairs. The resulting structures are shown in Fig. 8a and 
8b. Before interaction, the average stacking distance between base pairs was 3.51 Å. When the 
[CuL(OH2)]
+ complex (that formed when one aqua ligand from the solvent occupies the forth position 
in the square-planar polyhedron around the metal center) is inserted between A−U base pairs, stacking 
interactions in the intercalated system remain. As summarized in Table 1, the average distance 
between the upper A−U base-pair and [CuL(OH2)]
+ is 3.51 Å, whereas it is 3.42 Å between the bottom 
A−U base-pair and [CuL(OH2)]
+, the π–π stacking interaction of the latter being stronger compared to 
the upper base pairs. Moreover, the system is stabilized by a very strong H bond between the aqua 
ligand of [CuL(OH2)]
+ and one oxygen of uracil, Oaqua···Ouracil 2.70 Å (Fig. 8b). Same calculations 
were performed for free poly(rG)poly(rC) and [CuL]+/poly(rG)poly(rC), obtaining a preference for 
intercalation over external binding. The resulting structures are depicted in Fig. 8C and 8D. 
Intercalation of [CuL]+ into G-C sequences promotes a higher base pair separation (4.77 Å and 3.88 Å 
to upper and bottom base pair respectively) than that obtained for poly(rA)poly(rU), which causes 
that hydrogen interaction between [CuL]+ and the base pairs no longer exists. Thus, the stability of 
intercalated [CuL]+ in RNA (A-U) sequences is 40.67 kcal/mol more stable than in RNA (G-C) 
sequences. In order to compare [CuL]+/RNA with [CuL]+/DNA behavior similar calculations were 
performed for DNA poly(dG)poly(dC) but no convergence of the calculation was possible, thus 
confirming the experimental results where no interaction of [CuL]+ with poly(dG)poly(dC) was 
observed18 and the RNA recognition by [CuL]+. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8. QM/MM optimized structures of (a) free poly(rA)•poly(rU), (b) [CuL]+/poly(rA)•poly(rU), (c) free 
poly(rG)•poly(rC) and (d) [CuL]+/poly(rG)•poly(rC)in water. Colouring: C (grey), H (pink), O (red), S (yellow), 
P (brown) and Cu (green). 
 
An analysis of the resulting RNA conformations from the optimizations for both free and bound RNA 
confirms the intercalative mode of binding of the dye. The optimized structures for free and bound 
RNA clearly visualize the elongation of the base-pair distance caused by intercalation. The small RNA 
base-pairs studied are considerably flexible and the possible orientations of the A-U and G-C units do 
(b) 
(a) (c) 
(d) 
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not provide essential information about the system when x and y axes are analyzed. Nonetheless, the 
Rise and Twist parameters for z axis (interpreted as the distance between base pairs and the unwinding 
angle respectively) can be obtained; these are the two main parameters considered for intercalation. 
The Rise parameter changed from 2.95 Å for free poly(rA)poly(rU) to 6.2 Å when [CuL]+ 
intercalates, and from 3.29 Å to 7.07 Å in the case of poly(rG)poly(rC). Thus, the 100% increase in 
RNA elongation concurs with the first branch observed in viscosity measurements (Fig. 7b). The high 
value obtained for the Rise parameter could explain the huge n’ value calculated above (n’= 10) since 
strong distortion of a site implies exclusion of the adjacent sites. The long distance between the A–U 
base pairs due to intercalation entails a non-cooperative behaviour. Moreover, insertion of the dye in 
the hydrophobic environment of the polynucleotides involves unwinding followed by decrease in 
helicity. Therefore, the twist parameter evolves from 34.56° to 23.37°, showing 11.19° unwinding 
angle (Table 1) which is greater than the obtained after [CuL]+ intercalation in (2.29°) 
poly(rG)poly(rC). Scheme 3d schematically represents the complex intercalated into RNA. 
 
Table 1. Average distances, Rise and Twist values for free  poly(rA)•poly(rU) and [CuL]+/poly(rA)•poly(rU) 
systems, obtained from QM/MM optimizations. 
 
System 
Upper 
[CuL]+/AU, 
GC distance, 
(Å) 
Lower 
[CuL]+/AU, 
GC distance, 
(Å) 
Rise, 
(Å) 
Twist, 
(º) 
Free poly(rA)•poly(rU) - - 2.95 34.56 
[CuL]+/poly(rA)•poly(rU) 3.52 3.42 6.20 23.37 
Free poly(rG)•poly(rC) - - 3.29 30.30 
[CuL]+/poly(rG)•poly(rC) 4.77 3.88 7.07 28.01 
 
Spectrophotometric titrations of the [CuL]+/poly(rA)poly(rU) system were carried out at 0.0025, 0.10 
and 1.0 M ionic strength. The spectral changes recorded upon addition of increasing amounts of 
poly(rA)poly(rU) to a [CuL]+ solution, up to saturation, were smaller as the ionic strength rose; Fig. 
9a shows the spectra recorded for I = 0.0025 M. The binding isotherm (Fig. 9a, inset) reveals the 
formation of the [CuL]+/poly(rA)poly(rU) complex (PD), according to Eq. 1. The equilibrium 
constant, K, can be calculated by Eq. (2), 
                  
                                                          (2) 
where the polymer free-site concentration is expressed as [P] = CP × f(r), with f(r) =[1 − nr]
n/[1 − (n − 
1)r](1 − n). Evaluation of the concentration of polynucleotide free binding sites in equilibrium, [P], 
requires knowledge of the site size, n, defined as the number of base-pairs occupied by a bound drug 
molecule under saturation conditions.42 The intersection of the two branches of the spectrophotometric 
titration curves yields the n value at the X axis,43 (Fig. 9a, inset). The value obtained, n = 2, indicates 
that, for the [CuL]+/poly(rA)•poly(rU) saturated complex, one could expect one [CuL]+ molecule 
every two A−U base-pairs, whereas for low CD/CP ratio it turned out n´= 10 in the intercalated 
complex (see above). That is, an intercalated-external-aggregate complex can be formed, in which five 
[CuL]+ units exist every ten base-pairs (roughly, a full helix turn); therefore, one [CuL]+ molecule is 
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intercalated and the other four molecules (possibly forming two dimers, see Scheme 3e) are externally 
bound. 
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Fig. 9. a) Absorption spectra of the [CuL]+/poly(rA)•(rU) system and binding isotherm at λ = 382 nm (Inset). b) 
Linear fitting of equation 2 to the spectrophotometric data. CD = 26 µM, CP/CD = 0 − 15, I = 2.5 mM, pH = 6 .0 
and T = 25 ºC.  
 
Literature on the solid-state structure confirms the tendency of the [CuL]+ entities to forming 
polynuclear compounds (mainly dinuclear) through covalent bond, in which thioamide S (S-bridged 
systems) and ancillary X ligand (X_bridged systems) play an important role.3,25,44,45 In particular, it is 
noticeable the crystal structure of [{CuL(OH2)}2]
2+ S-bridged dimers recently reported,45 very close to 
those proposed here. Except for Hcyt, our structural studies with nucleobases support this tendency. In 
addition, a wide range of noncovalent interactions (mainly hydrogen bond and π−π stacking) support 
the formation of aggregates in the crystals of these ternary species, presumably due to their planarity 
and the presence of heteroatoms. Even though previous studies have described the collapse of the 
polynuclear entities in solution to give monomeric [CuL(OH2)n]
+ entities,46 recently published works 
have also detected [Cu2L3]
+ species at neutral pH.47 All these features provide structural support for 
the aggregate formation in the vicinity of RNA.  
Thus, the externally bound molecules forming dimers are responsible for the shortening of RNA, the 
observed diminution of relative viscosity for CD/CP > 0.1 evincing the interaction of the 
thiosemicarbazonecopper(II) on the RNA surface (Fig. 7b). These results are in full agreement with 
the DSC melting experiments for CD/CP > 0.1, the [CuL]
+ dimers located outside the helix having no 
influence on Tm (Fig. 7a). This finding has led us to assume that the intercalated thiosemicarbazone 
complex favours an ordered architecture along the RNA surface. Scheme 3e outlines the bifunctional 
external-intercalated complex. The π−π stacking interactions between thiosemicarbazonecopper(II) 
units are similar to those shown in Scheme 3a, whereas the intercalated complex is formed by 
interaction between thiosemicarbazones and biomolecules, such as those indicated in Scheme 3c. In 
other words, the π−π stacking interactions are present both in the solid state and in solution, both in 
the absence and in the presence of RNA.    
The binding constants calculated by means of eqn 2 (Fig. 9b), differ by almost an order of magnitude, 
from (4.5 ± 0.7) × 104  M−1 at I = 2.5 mM to (6.5 ± 0.7) × 103 M−1 at I = 0.1 M and are too low to be 
evaluated precisely at I = 1 M. This behaviour indicates that electrostatic interactions are also present 
in the formation of [CuL]+/poly(rA)•poly(rU) complex. The interaction between the positive charge of 
the copper dimers and the phosphate groups also play a key role that makes the formation of an 
external complex easier.  
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Is there any structural support for the way in which the thiosemicarbazonecopper(II) aggregates are 
linked to RNA? Unfortunately, we have not succeed in crystallizing nucleotide derivatives and, as the 
N9 (Hade) atom is linked to the ribose sugar in nucleotides, covalent bonds observed for our 
compounds in solid state between Cu(II) and N9 (Hade) are absent in RNA. On the other hand, 
previous chemical and crystallographic studies have described compounds in which phosphate groups 
bind to [CuL]+ fragments such as [(CuL)4P2O7]·nH2O
48  and [{Cu(HL)(H2PO4)}2](H2PO4)2· 
2H3PO4·2H2O.
49 Likewise, careful study of the structures of 18 mononucleotidecopper(II) derivatives 
extracted from the Cambridge Structural Database (CSD),50 reveals no appreciable influence of anion-
π interactions through the phosphate moieties, but rather coordination of the metal ions to at least two 
different phosphate oxygen atoms and setting of strong H bonds involving the phosphate groups. 
However, the coordination ability of the mononucleotide phosphate groups for the [CuL]+ entities in 
water seems to be relatively low, perhaps due to the terdentate nature of HL against the maximum 
bidentate behaviour of the ancillary ligands that constitute the mononucleotidecopper(II) complexes in 
the Database. By contrast, although solution studies should reveal interaction between [CuL]+ entities 
and H2dTMP or H2UMP, actually no reaction has been observed. This fact does not exclude the 
presence of electrostatic interactions with the phosphate scaffold in the RNA macromolecule, which 
seem to dominate in the reaction of [CuL]+ and [CuL’]+ derivatives with synthetic DNA [poly(dG-
dC)]2 and ct-DNA.
18 Therefore, the tendency of these thiosemicarbazonecopper(II) systems to forming 
H bonds could lead to noncovalent links with the phosphate groups in the macromolecular nucleotides. 
Lastly, the Circular Dichroism (CD) spectra recorded at different CD/CP ratios show significant 
structural changes in the RNA double helix (Fig. 10). The molar ellipticity at λ = 300 nm increases 
with the concentrations ratio and the positive band of RNA suffers a 3 nm bathochromic shift, 
characteristic of intercalating agents.51 
The set of results gathered reveals that formation of the [CuL]+/poly(rA)poly(rU) complex is 
governed by different types of interactions. That is, with the exception of covalent links, under 
physiological conditions the same noncovalent interactions observed in the solid state are at work in 
[CuL]+/RNA solutions. This behaviour differs from that observed with DNA. Groove binding occurs 
with [poly(dA–dT)]2, whereas it acts as an external binder with [poly(dG–dC)]2 and/or ct-DNA. 
[CuL]+ intercalates into RNA only at low concentration, CD/CP ≤ 0.1; that is, the concentration and 
type of polynucleotide, DNA or RNA, plays a key role in the biological interaction of [CuL]+. A 
similar behaviour, groove binding in DNA A-T tracts and intercalation in RNA, has been observed 
with cationic drugs such as Hoechst 33258, berenil or DAPI, which are considered to display 
molecular recognition since the binding may lie within duplex areas adjacent to bulges or loops, where 
such opening is available for threading intercalation to occur.21 21 Thiosemicarbazonecopper(II) flat 
entities open a new avenue for medical applications blocking biological events related to RNA. 
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Fig. 10. CD spectra for the [CuL]+/poly(rA)•poly(rU) system and molar ellipticity at λ = 300 nm (inset).  
 
 
Conclusions 
Ternary compounds containing thiosemicarbazonecopper(II) [CuL]+ entities linked to Hade, Hcyt and 
9-Mgua have been synthesized and characterized in solid state. For the first time, we describe here 
adenine- and guanine-containing thiosemicarbazone compounds and their structures. As far as we are 
aware, [(CuL)2(Hade)][{CuL}{CuL(OClO3)}(ade)](ClO4)2·2H2O (2) represents the first compound 
whose crystal structure contains, clearly differentiated, both neutral and anionic adenines, and 
[{CuL(9-Mgua)}2(OH2)](ClO4)2 (3) the unique one containing first-transition metal ions linked to S-
donor ligands and guanine. Under the experimental conditions employed, no reaction is observed with 
thymine and uracil. A plethora of noncovalent interactions stabilize the lattice in the crystal structures 
reported, in particular hydrogen bonds, π−π stacking and anion−π interactions. The spectroscopic and 
magnetic properties also show the influence of these noncovalent linkages, which can illustrate the 
behaviour observed in the reaction of [CuL]+ complexes with RNA in near physiological conditions. 
An intercalated, very stable [CuL]+/RNA complex is formed for low Cu-thiosemicarbazone 
concentrations, [CuL]+ < 0.1 [RNA]. Computational studies reveal that this intercalative behaviour 
could be due to both the strong π−π stacking and hydrogen bond interactions. The latter involves the 
aqua ligand of [CuL(OH2)]
+ species and the oxygen atom of a carbonyl group from uracil. In fact, the 
presence of two carbonyl groups in uracil, keeping one of them available for establishing hydrogen 
bonding with non-nucleobase fragments, could also influence, at least in part, the great tendency for 
the intercalation into RNA at low concentrations. This very relevant interaction indicates that [CuL]+ 
could play an important role in medical applications by blocking biological events related to RNA. 
When the [CuL]+/RNA ratio is raised, an external complex is formed from the intercalated. The 
different behaviour of [CuL]+ against DNA and RNA suggests a marked role of the macromolecule 
conformation in the type and intensity of the interactions. 
 
Experimental Section 
Chemicals. Copper(II) nitrate trihydrate, copper(II) perchlorate hexahydrate, sodium hydroxide, 
thiosemicarbazide, pyridine-2-carbaldehyde, cytosine, thymine, guanine, 9-methylguanine, adenine, 
adenosine-5´-monophosphate monohydrate and adenosine-5´-triphosphate disodium salt hydrate were 
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purchased from commercial sources and used as received. Published methods were used to synthesize 
HL, 52  HL´, 53  CuL(NO3)
54  and [{CuL´(ONO2)}2].
55  Aqueous solutions of uracil, 9-Mgua and 
poly(rA)poly(rU) were prepared by dissolving the lyophilized sodium salts in doubly distilled water 
from a Millipore Q apparatus (APS, Los Angeles, California). Aqueous solutions of CuL(NO3) 1 mM 
were used as source of [CuL]+ entities. Stock solutions were prepared in [NaClO4] = 0.1 or 1 M, using 
2.5 mM sodium cacodylate [Na(CH3)2AsO2] as a buffer to maintain the pH at 6.0. The 
poly(rA)poly(rU) concentration as base pairs molarity was evaluated spectrophotometrically at λ = 
260 nm using ε = 14900 M-1cm-1. The nucleobases and polynucleotide concentration is denoted as CP 
and, in the case of the poly(rA)poly(rU), is expressed in molarity of base-pairs, MBP. The stock 
solutions of nucleobases and polynucleotide were kept in the dark at 4 ºC whereas the aqueous 
solutions of the dyes were freshly prepared. CAUTION: Perchlorate salts and their respective metal 
complexes can be explosive and use of only small amounts of reactants is strongly recommended. 
Synthesis of ternary thiosemicarbazone-nucleobase-copper(II)  compounds. 
[{CuL}{CuL(OH2)}(ade)](ClO4) (1) and [(CuL)2(Hade)][{CuL}{CuL(OClO3)}(ade)](ClO4)2·2H2O 
(2). An amount of Hade (0.5 mmol, 0.068 g) was dissolved in water (30 ml) and its pH adjusted to 7.4 
with NaOH 1 M. An aqueous solution (35 ml) containing Cu(ClO4)2·6H2O (0.5 mmol, 0.185 g) and 
HL (0.5 mmol, 0.090 g) was stirred for 30 min and, afterwards, poured into the Hade one. The pH of 
the resulting mixture was raised to 7.4 by adding NaOH and the suspension was stirred for 2 h. A dark 
green solid of 1 was filtered off (yield 87 %, 0.161 g). Anal. found: C, 30.58; H, 2.68; N, 24.72; S, 
8.60. Calc. for C19H20ClCu2N13O5S2 (737.13 g/mol): C, 30.96; H, 2.73; N, 24.70; S, 8.70. IR bands 
(cm–1, KBr pellet): 3418 s, 3336 s, 3165 m, 1644 s, 1605 s, 1559 w, 1484 m, 1451 vs, 1439 w, 1400 w, 
1383 w, 1357 w, 1325 m, 1297 m, 1266 w, 1226 m, 1171 s, 1151 s–υ3(ClO4
–), 1111 s–υ3(ClO4
–), 1090 
s–υ3(ClO4
–), 973 m–υ2(ClO4
–), 905 m, 880 m, 772 m, 742 m, 625 m, 520 w, 451 m–υ1(ClO4), 412 m. 
Q-band EPR signals at RT: g1 = 2.175, g2 = 2.052 and g3 = 2.043. Single crystals of compounds 1 and 
2 suitable for X-ray diffraction measurements were obtained as follows: solid HL (0.5 mmol, 0.090 g) 
was slowly added to Cu(ClO4)2·6H2O (0.5 mmol, 0.185 g) in water (30 ml). On the other hand, solid 
Hade (0.5 mmol, 0.068 g) and 20 ml MeOH were poured into an aqueous solution (20 ml) of 
Cu(ClO4)2·6H2O (0.5 mmol, 0.185 g) at pH 5−6 by addition of NaOH. Both solutions were stirred 
separately for 1 h and, afterwards, that containing methanol was dropwise added onto the other and the 
mixture stirred for 2 h. Slow evaporation in air of the resulting solution yielded crystals of 1 and 2.  
[(CuL)2(Hade)][{CuL}{CuL(OClO3)}(ade)](ClO4)2·2H2O (2). Several experimental procedures were 
carried out to develop a rational method to attain 2. As a result, different solids were obtained showing 
elemental analysis and spectroscopic properties in good agreement with the presence of different 
hydration degrees per unit formula, ranging from 2 (compound 2) to 10 water molecules. The fully 
characterized and reproducible phase was performed as follows. Hade (1.0 mmol, 0.136 g) and HL 
(1.0 mmol, 0.180 g) were dissolved in a refluxing water:methanol (1:1) mixture at 50 ºC for 2 h. 
Afterwards, Cu(ClO4)2·6H2O (1.0 mmol, 0.371 g) in 10 ml of methanol was poured into the ligands 
solution and kept with stirring at room temperature for 1 h. The solution was filtered off to eliminate 
insoluble impurities and was left for slow evaporation in air during several days. Dark blue-greenish 
crystals were isolated (yield 53 %, 0.214 g). Anal. found: C, 28.74; H, 2.85; N, 22.91; S, 7.89. Calc. 
for C38H41Cl3Cu4N26O14S4 (1574.72 g/mol): C, 28.98; H, 2.62; N, 23.13; S, 8.15. IR bands (cm
–1, KBr 
pellet): 3430 w, 3312 s, 3118 s, 1650 vs, 1603 vs, 1572 w, 1490 s, 1447 vs, 1406 w, 1314 w, 1227 m, 
1227 m, 1170 m, 1157 s–υ3(ClO4
–), 1111 s–υ3(ClO4
–), 1061 vs–υ3(ClO4
–), 917 m, 876 m, 774 m, 723 
m, 618 m–υ4(ClO4
–), 514 m, 450 w, 416 m. FAB+ mass spectrometry (m/z): 241.88 [CuL]+, 376.89 
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[CuL(Hade)]+, 619.74 [(CuL)2(Hade)]
+. X-band EPR signal of polycrystalline powder at RT: g = 
2.079.  
{CuL(9-Mgua)}2(OH2)](ClO4)2 (3). Solid Cu(ClO4)2·6H2O (0.3 mmol, 0.112 g) and HL (0.6 mmol, 
0.118 g) were dissolved in 20 ml of a water:MeOH 1:1 solvent mixture. The pH of this solution was 
raised from 2.5 to 6.2 dropping 1 M aqueous NaOH. In a different baker, a solution of 
Cu(ClO4)2·6H2O (0.3 mmol, 0.112 g) in 10 ml water was added to a suspension of 9-Mgua (0.6 mmol, 
0.112 g) in 20 ml of water:MeOH 1:1. These solutions were stirred separately for 30 min. Afterwards, 
the former was poured drop by drop into the latter. Next, the acidity was adjusted at pH 6.5 by adding 
NaOH 1 M and a green solid was filtered off (0.158 g). After 6 weeks, slow evaporation of mother 
liquors at room temperature yielded few single crystals of 3 suitable for X-ray diffraction 
measurements.  
A new way to attain powdery samples was optimized. Cu(ClO4)2·6H2O (0.5 mmol, 0.185 g) was 
dissolved in 7 ml of distilled water. Solid 9-Mgua (0.5 mmol, 0.0832 g) was added and NaOH 1 M 
was dropped into to pH 6, whereas the reaction was stirred for 1 h. Then, solid HL (0.5 mmol, 0.090 g) 
was added, the pH was adjusted to 6 and the mixture was stirred for 3 h. A brown-greenish precipitate 
was filtered off and washed with water and acetone (yield 65 %, 0.335 g). Anal. found: C, 30.19; H, 
3.30; N, 24.16; S, 6.15. Calc. for C26H30Cl2Cu2N18O11S2 (1032.78 g/mol): C, 30.24; H, 2.93; N, 24.41; 
S, 6.21. IR bands (cm–1, KBr pellet): 3464 s, 3397 s, 3278 w, 3160 s, 1683 vs, 1653 vs, 1626 vs, 1594 
vs, 1557 s, 1496 m, 1480 m, 1427 vs, 1412 s, 1374 w, 1328 m, 1290 w, 1228 m, 1167 s, 1153 s (υ3-
ClO4
–), 1112 vs (υ3-ClO4
–), 1068 vs (υ3-ClO4
–), 934 w, 914 w (υ1-ClO4
–), 890 w, 877 m, 777 m, 728 
m, 692 w, 666 w, 624 s (υ4-ClO4
–), 523 m, 478 m, 444 m, 413 m. FAB+ mass spectrometry (m/z): 
242.02 [CuL]+, 407.03 [CuL(9-Mgua)]+, 648.00 [(CuL)2(9-Mgua)]
+. X-band EPR signal of 
polycrystalline powder at RT: g|| = 2.140 and g⊥ = 2.042. 
[CuL(Hcyt)](ClO4)·2H2O (4). Solid HL (0.5 mmol, 0.090 g) was added to a solution of 
Cu(ClO4)2·6H2O (0.5 mmol, 0.185 g) in 30 ml of water. On the other hand, Cu(ClO4)2·6H2O (0.5 
mmol, 0.185 g) was dissolved in 20 ml of water, basified up to pH = 5-6 with diluted NaOH. Then, 20 
ml MeOH were poured into the solution. Next, solid Hcyt (0.5 mmol, 0.063 g) was added to the last 
mixture. Both solutions were stirred for 1 h and filtered off. Afterwards, the solution with Hcyt was 
dripped over the solution with [CuL]+ entities. The resulting dark green solution was stirred at room 
temperature for 2 h and it was kept at room temperature. After few days, slow evaporation of the 
mother liquors yielded dark green single crystals suitable for X-ray diffraction measurements. Anal. 
found: C, 27.09; H, 3.11; N, 19.98; S, 6.37. Calc. for C11H16ClCuN7O7S (489.36 g/mol): C, 27.00; H, 
3.30; N, 20.04; S, 6.55. IR bands (cm–1, KBr pellet): 3430 s, 3318 s, 3113 m, 1682 s, 1632 vs, 1564 w, 
1526 m, 1485 w, 1449 s, 1441 s, 1378 w, 1322 m, 1298 w, 1274 w, 1231 m, 1172 w, 1151 m (υ3-
ClO4
–), 1109 s (υ3-ClO4
–), 1087 vs (υ3-ClO4
–), 911 m (υ1-ClO4
–), 880 m, 792 w, 776 m, 765 m, 741 m, 
730 m, 629 s (υ4-ClO4
–), 516 m. FAB+ mass spectrometry (m/z): 242.09 [CuL]+, 353.07 [CuL(Hcyt)]+. 
Q-band EPR signals at RT: g1 = 2.168, g2 = 2.048 and g3 = 2.033.  
[CuL(Hcyt)](ClO4) (5). The structure and characterization of this complex has been published 
previously by our group.17 Here, we present a rational synthetic procedure for its achievement and 
EPR characterization not reported so far. A solution of Cu(ClO4)2·6H2O (0.5 mmol, 0.185 g) and HL 
(0.5 mmol, 0.090 g) in 20 ml water was stirred for 30 min. Next, a solution of Hcyt (0.5 mmol, 0.063 
g) in 10 ml of same solvent was poured into it and the pH was adjusted to 4 by adding NaOH 0.1 M. 
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The mixture was stirred for 24 h. Afterwards, a green solid was filtered off, washed with water and 
dried over vacuum (25 %, 0.056 g). Q-band EPR signals at RT: g1 = 2.169, g2 = 2.047 and g3 = 2.037. 
(CuL)2(cyt)(ClO4)(H2O)2 (6). A solution of Cu(ClO4)2·6H2O (0.5 mmol, 0.185 g) and HL (0.5 mmol, 
0.090 g) in 20 ml of water was stirred for 30 min. Next, a solution of Hcyt (0.5 mmol, 0.063 g) in 10 
ml of the same solvent was poured, the pH was adjusted to 7.4 and it was stirred for 2 h. Finally, a 
green solid was isolated (24 %, 0.044 g). Anal. found: C, 29.27; H, 3.18; N, 20.94; S, 8.99. Calc. for 
C18H22ClCu2N11O7S2 (731.11 g/mol): C, 29.57; H, 3.03; N, 21.07; S, 8.77. IR bands (cm
–1, KBr pellet): 
3410 m, 3317 m, 3184 m, 3085 m, 1640 s, 1602 s, 1567 m, 1533 m, 1487 m, 1448 w, 1436 vs, 1379 
w, 1322 m, 1293 m, 1269 w, 1231 m, 1170 s, 1149 s (υ3-ClO4
–), 1109 s (υ3-ClO4
–), 1087 s (υ3-ClO4
–), 
880 m, 776 m, 737 m, 627 m (υ4-ClO4
–), 558 m, 456 w (υ3-ClO4
–). FAB+ mass spectrometry (m/z): 
242.05 [CuL]+, 353.05 [CuL(Hcyt)]+, 483.97 [Cu2L2]
+, 594.00 [(CuL)2(cyt)]
+. Q-band EPR signals at 
RT: g1 = 2.173, g2 = 2.053 and g3 = 2.037. 
(CuL)2(cyt)(NO3)(H2O)2 (7). The compound CuL(NO3) (1 mmol, 0.305 g) was dissolved in 100 ml 
water at 50 ºC and Hcyt (1 mmol, 0.112 g) was added as a solid. The mixture was stirred for 2 h at 
room temperature and then (pH = 4.5), it was filtered off. A dark green solid (54 %, 0.187 g) was 
washed with water and acetone and dried over vacuum. Anal. found: C, 31.50; H, 3.19; N, 24.62; S, 
8.92. Calc. for C18H22Cu2N12O6S2 (693.67 g/mol): C, 31.17; H, 3.20; N, 24.23; S, 9.24. IR bands (cm
–1, 
KBr pellet): 3404 m, 3320 m, 3107 m, 1645 vs, 1605 s, 1593 s, 1570 s, 1532 s, 1486 s, 1445 vs, 1384 
s (υ3-NO3
–), 1352 s, 1317 m, 1294 s, 1262 m, 1228 s, 1169 vs, 1153 m, 917 w, 881 m, 823 w (υ2-NO3
–
), 800 w, 789 w, 776 m, 737 m, 684 w, 627 m, 600 w, 524 w, 496 w, 457 w, 418 w. Q-band EPR 
signals at RT: g|| = 2.052 and g⊥ = 2.110.  
CuL´(Hcyt)(NO3)(H2O) (8). The preparation method for this compound was the same as the previous 
one but, in this case, the reagent was [{CuL´(ONO2)}2] (0.5 mmol, 0.319 g) instead of (CuL)(NO3). 
After 2 h of vigorous stirring the solution pH was 7.2, and 15 days later, a dark green solid was filtered 
off, washed with water and acetone and dried over vacuum (12 %, 0.053 g). Anal. found: C, 32.58; H, 
3.88; N, 24.65; S, 7.35. Calc. for C12H16CuN8O5S (447.92 g/mol): C, 32.18; H, 3.60; N, 25.02; S, 7.16. 
IR bands (cm–1, KBr pellet): 3450 w, 3279 m, 3082 m, 1683 m, 1651 w, 1630 vs, 1589 w, 1569 w, 
1529 s, 1478 w, 1447 w, 1371 w, 1354 vs (υ3-NO3
–), 1312 m, 1289 s, 1225 s, 1179 w, 1154 w, 1115 
m, 1099 w, 1035 m, 907 m (υ2-NO3
–), 783 w, 771 w, 741 w, 686 w, 650 w, 612 w, 560 w, 543 w, 518 
w, 492 vw, 444 vw, 414 w. FAB+ mass spectrometry (m/z): 256.05 [CuL´]+. Q-band EPR signals at 
RT: g1 = 2.172, g2 = 2.050 and g3 = 2.035. 
(CuL)2(ade)(NO3)(H2O)5 (9). The compound CuL(NO3) (0.5 mmol, 0.152 g) was dissolved in 50 ml of 
water at 50 ºC. Once dissolved, a solution of Hade (0.5 mmol, 0.068 g) in water (30 ml) was added 
and the resulting mixture was stirred for 2 h at room temperature, while pH is adjusted at pH 7.4 by 
addition of NaOH. A month later, dark green crystals were collected, but they decomposed 
immediately after removing the solvent. Several attempts to stabilize crystals of this compound were 
unsuccessful. Anal. found: C, 29.95; H, 3.65; N, 25.24; S, 7.95. Calc. for C19H28Cu2N14O8S2 (771.70 
g/mol): C, 29.57; H, 3.66; N, 25.41; S, 8.31. IR bands (cm–1, KBr pellet): 3402 s,b, 3305 w,sh, 3159 
m, 1637 s, 1602 s, 1558 w, 1491 m, 1446 s, 1384 m (υ3-NO3
–), 1321 w, 1296 w, 1226 m, 1170 m, 
1151 m, 1107 m, 908 m, 879 w, 827 w (υ2-NO3
–), 772 w, 725 w, 658 w, 623 w, 517 w, 414 w. FAB+ 
mass spectrometry (m/z): 242.13 [CuL]+, 377.08 [CuL(Hade)]+, 484.03 [Cu2L2]
+, 618.10 
[(CuL)2(ade)]
+.  
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Synthesis of ternary thiosemicarbazone-nucleotide-copper(II)  compounds. (CuL)2(AMP)(H2O)8 
(10). H2AMP (0.2 mmol, 0.073 g) was dissolved in water (10 ml) and pH fixed at 6.0 by addition of an 
aqueous NaOH solution. Solid HL (0.4 mmol, 0.072 g) was slowly added to a solution of 
Cu(ClO4)2·6H2O (0.4 mmol, 0.148 g) in water (10 ml), and the green solution was stirred for 30 min 
and, afterwards, filtered over the nucleotide solution. The mixture was allowed to react for 1 h and the 
pH set to 6.0 with NaOH. A dark green solid is collected, washed with water and acetone and dried 
over vacuum (53 %, 0.127 g). Anal. found: C, 29.57; H, 4.16; N, 18.46; S, 6.68. Calc. for 
C24H42Cu2N13O15PS2 (974.86 g/mol): C, 29.57; H, 4.34; N, 18.68; S, 6.58. IR bands (cm
–1, KBr pellet): 
3437 s, 3278 m, 3128 s, 1649 m, 1630 s, 1601 s, 1558 w, 1482 s, 1450 s, 1437 s, 1380 w, 1318 w, 
1292 w, 1229 m, 1170 s, 1107 s (υ3-PO4
3–), 1087 s (υ3-PO4
3–), 976 m, 911 m, 880 d, 783 m, 731 w, 
696 w, 625 m, 520 w (υ4-PO4
3–), 471 w, 420 w. Q-band EPR signals at RT: g1 = 2.188, g2 = 2.067 and 
g3 = 2.041. 
(CuL’)2(AMP)(H2O)8 (11). The method was basically the same as that previously described, using HL’ 
(0.4 mmol, 0.078 g) instead of HL. Dark green solid, (51 %, 0.127 g). Anal. found: C, 31.01; H, 4.58; 
N, 18.29; S, 6.00. Calc. for C26H46Cu2N13O15PS2 (1002.92 g/mol): C, 31.14; H, 4.62; N, 18.16; S, 6.39. 
IR bands (cm–1, KBr pellet): 3394 s,b, 3337 w,sh, 3218 s, 1636 s, 1595 m, 1574 m, 1531 s, 1497 m, 
1464 s, 1393 s, 1355 m, 1307 m, 1244 m, 1174 s,1125 s (υ3-PO4
3–), 1075 s (υ3-PO4
3–), 979 s, 886 w, 
776 w, 724 w, 624 w, 520 w (υ4-PO4
3–), 416 w. FAB+ mass spectrometry (m/z): 256.07 [Cu(L’)]+. Q-
band EPR signals at RT: g1 = 2.183, g2 = 2.066 and g3 = 2.048. 
(CuL)3(H2ATP)(ClO4)(H2O)8 (12). Cu(ClO4)2·6H2O (0.3 mmol, 0.111 g) was dissolved in water (20 
ml) and solid HL (0.3 mmol, 0.054 g) was added. After 30 min, the mixture was filtered over a 
Na2H2ATP·nH2O solution (0.3 mmol, 0.165 g) in water (30 ml). The resulting solution was basified to 
pH 7.4 by addition of diluted NaOH. The reaction was kept for 2 h, being the pH restored to 7.4. No 
precipitation was observed and the green solution was allowed to rest for slow evaporation. One 
month later, a dark green solid appeared, (44 %, 0.064 g). Anal. found: C, 25.42; H, 3.50; N, 16.11; S, 
6.52. Calc. for C31H51ClCu3N17O25P3S3 (1473.92 g/mol): C, 25.21; H, 3.48; N, 16.12; S, 6.37. IR bands 
(cm–1, KBr pellet): 3407 s, 3298 w,sh, 3148 s, 1640 s, 1605 s, 1559 w, 1487 m, 1450 s, 1437 s, 1380 
m, 1322 w, 1296 m, 1229 s, 1171 s, 1156 w,sh (υ3-ClO4
–)/(υ3-PO4
3–), 1091 s (υ3-ClO4
–)/(υ3-PO4
3–), 
908 m, 878 w, 824 w, 773 w, 725 w, 627 w, 557 w, 521 w (υ4-PO4
3–), 416 w. Q-band EPR signals at 
RT: g1 = 2.170, g2 = 2.082 and g3 = 2.058. 
Physical measurements. The pH measurements were performed using a CRISON micro pH 2002 pH-
meter fitted out with a combined glass electrode with a 3 M KCl solution as a liquid junction. 
Microanalyses were performed with a LECO CHNS-932 analyzer. FAB+ mass spectrometry data were 
obtained on a Micromass AutoSpec. Thermal analysis measurements were performed in a Netzsch 
STA 449C and in a TA SDT 2960 instruments. Crucibles containing 20 mg samples were heated at 10 
ºC/min under dry air atmosphere. IR spectra were obtained with samples prepared as KBr pellets in the 
4000-400 cm–1 region on a Nicolett Impact 410 FTIR and a JASCO FT-IR 4200 spectrophotometer, 
the latter equipped with a Single Reflection ATR PRO ONE device. The intensity of reported IR 
bands are defined as vs = very strong, s = strong, m = medium and w = weak, while b stands for broad 
band. Room temperature X-band EPR spectra of powdered samples were recorded on a Bruker EMX 
spectrometer, equipped with a Bruker ER 036TM NMR-teslameter and an Agilent 53150A microwave 
frequency counter to fit the magnetic field and the frequency inside the cavity. Q-band measurements 
were carried out by a Bruker ESP300 spectrometer equipped with a Bruker BNM 200 gaussmeter and 
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a Hewlett-Packard 5352B microwave frequency counter to fit the magnetic field and the frequency 
inside the cavity. The simulation of the EPR spectra was performed using the SimFonia program.56 
The spectrophotometric titrations were performed on a Hewlett-Packard 8453A (Agilent 
Technologies, Palo Alto, CA) photodiode array spectrophotometer with a Peltier temperature control 
system. Titrations were carried out by adding increasing amounts of uracil or RNA (P) into the cell 
containing the [CuL]+ solution (D). The sample was not illuminated during the equilibration period. 
Circular dichroism (CD) measurements were performed with a MOS-450 Biological 
spectrophotometer (Bio-Logic SAS, Claix, France) fitted out with 1.0 cm path-length cells. Titrations 
were carried out at 25ºC by adding increasing amounts of [CuL]+ to the RNA solution. The thermal 
denaturation behaviour was studied by DSC measurements, using a Nano DSC Instrument (TA, 
Waters LLC, New Castle, USA). To avoid bubbles formation upon heating, the reference and the 
sample solutions were previously degassed in a degassing station (TA, Waters LLC, New Castle, 
USA). The samples were scanned at 3 atm pressure from 20 to 90 °C at 1 °C·min−1 scan rate. 
Viscosity measurements were performed using a Micro-Ubbelohde viscometer (Schott, Mainz, 
Germany) immersed in a water bath at 25 ºC. The flow time was measured with a digital stopwatch. 
Sample viscosities were evaluated as the mean value of at least three replicated measurements. The 
viscosity data were analysed using η/η0 = (t - t0)/(tRNA - t0), where t0 and tRNA are the solvent and 
polynucleotide solution flow times, respectively, whereas t is the flow time of the dye and 
poly(rA)·poly(rU)  mixture. The viscosity readings were reported as L/L0 = (η/η0)
1/3 versus CD/CP 
ratio,41 where η and η0 stand for the polynucleotide viscosity in the presence and in the absence of dye, 
respectively.  
Crystallographic structure determination. Crystal data collections were carried out on a Stoe IPDS 
I single-crystal diffractometer using monochromated MoKα radiation (λ = 0.71073 Å). Absorption 
corrections, when needed, were made using the Guassian integration. Direct methods (SIR97)57 were 
employed to solve the structures and then refined using the SHELXL-2013 computer program 58 within 
WINGX.59 The non-H atoms were refined anisotropically, using weighted full-matrix least-squares on 
F2. The H atoms (excluding those of the water molecules) were included in calculated positions and 
refined as riding atoms with default SHELXL parameters. Selected crystallographic and refinement 
details for the four crystal structures are shown in Table 2. A more complete set of experimental and 
resolution parameters is given in Table S1. CCDC 1400120-1400123 contain the supplementary 
crystallographic data for 1–4. These data can be obtained free of charge via 
http://www.ccdc.cam.ac.uk/conts/retrieving.html, or from the Cambridge Crystallographic Data 
Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: (+44) 1223-336-033; or e-mail: 
deposit@ccdc.cam.ac.uk. 
Computational details. In silico study was performed for the metal complex and RNA interaction 
with Gaussian 0960 software. Prior to that study, structure optimization of the dye and a two base-pair 
poly(rA)poly(rU) and poly(rG)poly(rC) were carried out by running DFT studies, in water. For 
[CuL(OH2)]
+ complex, ωB97X-D functional was employed, applying  6-31G basis with diffuse 
function (6-31G*) for light atoms (C, H O, N and S) and LANL2DZ for Cu, which has been employed 
by previous author in organometallic complexes.61  This basis set consists of a Dunning/Hazinaga 
valence double-zeta basis, containing ECP (effective core potential) representations of core electrons 
for third row elements and beyond. Inclusion of ECP method replaces core electrons with an effective 
potential which, apart from taking into account relativistic effects, it considerably diminishes the 
calculation time, while maintaining the reliability.     
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Table 2. Crystallographic data for compounds 1 - 4. 
 1 2 3 4 
Empirical formula  C19H20ClCu2N13O5S2 C38H41Cl3Cu4N26O14S4 C26H30Cl2Cu2N18O11S2 C11H16ClCuN7O7S 
Formula weight  737.13 1574.72 1032.78 489.36 
Temperature (K)  293(2) 293(2) 293(2) 293(2) 
Wavelength (Å)  0.71073  0.71073 0.71073  0.71073  
Crystal system  Monoclinic Monoclinic Monoclinic Triclinic 
Space group  P21/n P21/a I2/a P1 
A (Å) 9.120(2) 15.564(5) 17.661(10) 7.164(2) 
B (Å) 21.317(4) 22.845(18) 9.779(3) 11.561(7) 
C (Å) 13.736(3) 17.255(10) 22.809(8) 12.416(7) 
α (°) 90 90 90 98.38(6) 
β (°) 94.41(3) 97.41(6) 103.96(6) 104.31(4) 
γ (°) 90 90 90 99.69(6) 
Volume (Å3) 2662.5(9) 6084(6) 3823(3) 963.1(8)  
Z 4 4 4 2 
Density (calc.) (Mg/m3) 1.839 1.719 1.794 1.687 
Absorption coefficient (mm–1) 1.916 1.731 1.445 1.431 
R indices [I > 2σ(I)] R1 = 0.0503 R1 = 0.0688 R1 = 0.0470 R1 = 0.0571 
 wR2 = 0.0646 wR2 = 0.0980 wR2 = 0.1148 wR2 = 0.1219 
 
Two free base-pair poly(rA)poly(rU) and [CuL]+/2poly(rA)poly(rU) calculations were run with 
Quantum Mechanics/Molecular mechanics method, QM/MM. In QM/MM calculations the accuracy of 
Quantun Mechanics is combined with the speed of Molecular Mechanics. For this work, the QM part 
of the system was applied to uracil, Hade and [CuL(OH2)]
+ moieties, treated with the same method 
applied for free organometallic complex described above. The MM part of this calculation consists of 
the RNA backbone, and was studied with AMBER9462 force field, using electronic embedding for 
setting the charges of the RNA. Sodium atoms were added to the MM part in order to maintain the 
polynucleotide electroneutrality.  
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DNA parameters were analyzed with X3DNA 63  software, as the number of base pairs is short, 
dye/DNA interaction was analyzed in terms of one translational (Rise) and one angular base-pair step 
parameters (Twist).64 Rise parameter gives a value for adjacent base-pairs separation on the long axis 
(z axis) of polynucleotides and Twist shows the helix unwinding.  
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duplex RNA. Relevant noncovalent interactions both in 
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Intercalation of thiosemicarbazonecopper(II) [CuL]
+
 species into RNA at low concentration affords an 
increase of melting temperature of 28 ºC, in contrast to the behaviour observed for DNA. The crystal 
structures of ternary [CuL]+ / nucleobase compounds support the presence of strong non-covalent 
interactions, both in solid and solution, whose influence in the reactivity against DNA and RNA and 
biological relevance are discussed. 
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